Genome Engineering Market To Reflect Significant Incremental Opportunity During 2018-2026

Genome Engineering Market To Reflect Significant
Incremental Opportunity During 2018-2026
Genome Engineering Market, By Technology (CRISPR, TALEN, ZFN, and others),
By Application (Cell Line Engineering, and Genetic Engineering), By End User
(Biotechnology & Pharmaceutical Companies, Research Institutes, and Contract
Research Organizations) and by Geography - Global Trends and Forecast to
2025
The Global Genome Engineering Market was valued at US$ 2,582.7 Mn in 2016 and is expected to
witness a CAGR of 14.3% over the forecast period (2017–2025).
Genome engineering is a technique in which a DNA is inserted, deleted, modified or replaced in the
genome of a living organism. Research and development activities are conducted in genome
engineering for the development of novel technologies. For instance, in 2017, Synthego Corporation
launched a CRISPR Pioneers Program to expand genome engineering research. Researchers are
majorly focusing on developing treatments for cancer and rare diseases with the help of genome
engineering tools such as CRISPER. Many genome technologies are under trial for treatment of such
diseases, and are expected to receive approvals in the near future.
Market Dynamics
Development of novel technologies in genome engineering field is expected to significantly drive
growth of the global genome engineering market in the near future. For instance, in 2017, Merck
KGaA— Germany-based company—developed a new genome editing tool dubbed 'proxy-CRISPR',
providing access to previously inaccessible microenvironments of the genome by modification of
chromatin modifications. In 2017, Benson Hill Biosystems, Inc.—an agricultural technology company
—launched its latest CRISPR 3.0, to increase innovators’ access to gene editing. CRISPR 3.0 is a latest
innovative genomics tool, which is expected to improve crop performance. Development of such novel
technologies by major key players is expected to create a conducive environment for growth of market.
Detailed Segmentation:
•Global Genome Engineering Market, By Technology :
•CRISPR
•TALEN
•ZFN
•Others
•Global Genome Engineering Market, By Application:
•Cell Line Engineering
•Genetic Engineering
•Global Genome Engineering Market, By End User:
•Biotechnology & Pharmaceutical Companies
•Research Institutes
•Contract Research Organization
Increasing development of novel technologies in genome engineering is expected to drive growth
of the global genome engineering market in the near future
Key players in the market are focusing on developing novel technologies and launching new products
for genome engineering, in order to increase their market share. For instance, in February 2018,
Sangamo Therapeutics, Inc. received clinical trial authorization (CTA) from Medicines and Healthcare
Products Regulatory Agency (MHRA) in the U.K. for its SB-FIX, a zinc finger nuclease (ZFN)mediated in-vivo genome editing treatment for hemophilia B. CTA has allowed for the beginning of
Europe's first in-vivo genome editing study. In 2017, Integrated DNA Technologies, Inc. launched the
first Cas9 enzyme variant, which reduces off-target effects in CRISPR genome editing.
The launch of latest Cas9 enzyme variant is a major step towards therapeutic use of CRISPR. In 2017,
Scientists at Salk Institute for Biological Studies, modified CRISPR to epigenetically treat diabetes,
kidney disease, and muscular dystrophy. They developed a latest version of CRISPR/Cas9 genome
editing technology, which allows for activation of genes without creating breaks in the DNA. The
development of such novel technologies is expected to be major driving factor for growth of global
genome engineering market.
Ask For Sample Copy Of This Business Research Report :
https://www.coherentmarketinsights.com/insight/request-sample/1262
Increasing strategic collaboration for genome engineering technologies by key players is expected
to drive market growth in the near future
Players in the market are focusing on strategic collaborations, in order to increase their product
offerings. For instance, in February 2018, Kite Pharma, Inc.—a Gilead Sciences, Inc. company—
collaborated with Sangamo Therapeutics Inc. for developing engineered cell therapies to treat cancer.
As per the agreement, Kite Pharma, Inc. will use Sangamo Therapeutics’ zinc finger nuclease (ZFN)
gene-editing technology for developing next-generation ex vivo cell therapies for treatment of cancer.
Furthermore, in 2017, Synthego and Thermo Fisher Scientific collaborated to manufacture and
distribute synthetic guide RNA products for CRISPR genome engineering. In 2016, CRISPR
Therapeutics and Bayer AG collaborated and formed a joint venture Casebia Therapeutics, for
developing CRISPR-based therapeutics in select disease areas. Moreover, in 2017, Casebia
Therapeutics collaborated with CureVac AG.
Competitive Landscape
Key players operating in the genome engineering market include Thermo Fisher Scientific Inc.,
CRISPR Therapeutics AG, Intellia Therapeutics, Inc., Editas Medicine, Inc., Sangamo Therapeutics,
Inc., Bluebird Bio, Inc., Cellectis S.A., and Merck Group.
Moreover, increasing funding and investments for the development and research of new genetic
engineering technologies is also expected to drive market growth. For instance, in January 2018, the
U.S. National Institutes of Health (NIH) announced to grant US$ 190 million for genome editing
research. This new program, Somatic Cell Genome Editing, will award funds to biomedical researchers
over the following six years. The support from major research organizations such as NIH is expected to
attract more researchers in this field, which may lead to advancements in technology and also aid in
growth of the market.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: [email protected]

The Global Genome Engineering Market was valued at US$ 2,582.7 Mn in 2016 and is expected to witness a CAGR of 14.3% over the forecast period (2017–2025). Genome engineering is a technique in which a DNA is inserted, deleted, modified or replaced in the genome of a living organism.

Download Report